Strahm B, Rittweiler K, Duffner U, Brandau O, Orlowska-Volk M, Karajannis M A, Stadt U z, Tiemann M, Reiter A, Brandis M, Meindl A, Niemeyer C M
University Children's Hospital, Freiburg, Germany.
Br J Haematol. 2000 Feb;108(2):377-82. doi: 10.1046/j.1365-2141.2000.01884.x.
We present two male siblings suffering from recurrent manifestations of B-cell non-Hodgkin's lymphoma (NHL) and recurrent infections of the lower respiratory tract associated with bronchiectasis. Immunodeficiency could not be demonstrated by any laboratory investigation. In both patients, lymphomas developed without evidence for Epstein-Barr virus (EBV) infection, i.e. no antibody response to EBV-specific antigens, negative EBV-PCR (polymerase chain reaction) in peripheral blood cells, and absence of latent membrane protein (LMP) and EBV-encoded RNA (EBER) in lymphoma cells. Molecular analysis of the SH2D1A, the gene for X-linked lymphoproliferative disease (XLP) led to the identification of a deletion in the first exon in both patients. Therefore, we postulate that the genetic defect and the following dysregulation of the B-/T-cell interaction rendered these patients susceptible to the early onset of B-cell NHL and that EBV infection is not an obligate prerequisite.
我们报告了两名男性同胞,他们患有B细胞非霍奇金淋巴瘤(NHL)的复发性表现以及与支气管扩张相关的下呼吸道反复感染。任何实验室检查均未证实存在免疫缺陷。在这两名患者中,淋巴瘤的发生均无证据表明存在爱泼斯坦-巴尔病毒(EBV)感染,即对EBV特异性抗原无抗体反应、外周血细胞中EBV-PCR(聚合酶链反应)阴性,且淋巴瘤细胞中不存在潜伏膜蛋白(LMP)和EBV编码RNA(EBER)。对X连锁淋巴增殖性疾病(XLP)的基因SH2D1A进行分子分析,结果在两名患者的第一个外显子中均发现了缺失。因此,我们推测,这种基因缺陷以及随后B/T细胞相互作用的失调使这些患者易患早期B细胞NHL,且EBV感染并非必要前提条件。